Which stocks in any sector do Indian mutual fund managers prefer most? — August 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 41 | Shilpa Medicare Ltd | 30 funds | 1.13% | ₹801 Cr |
| 42 | AstraZeneca Pharma India Limited | 26 funds | 0.95% | ₹1,311 Cr |
| 43 | Sequent Scientific Limited | 26 funds | 0.73% | ₹691 Cr |
| 44 | Orchid Pharma Limited | 26 funds | 0.65% | ₹650 Cr |
| 45 | Procter & Gamble Health Limited | 24 funds | 1.67% | ₹865 Cr |
| 46 | Marksans Pharma Limited | 22 funds | 0.96% | ₹547 Cr |
| 47 | Akums Drugs and Pharmaceuticals Limited | 22 funds | 0.73% | ₹1,064 Cr |
| 48 | Senores Pharmaceuticals Ltd | 20 funds | 1.01% | ₹449 Cr |
| 49 | SUPRIYA LIFESCIENCE LIMITED | 19 funds | 0.63% | ₹103 Cr |
| 50 | Alivus Life Sciences | 18 funds | 0.80% | ₹527 Cr |
| 51 | Sanofi India Limited | 15 funds | 0.41% | ₹605 Cr |
| 52 | Innova Captab Limited | 15 funds | 0.78% | ₹559 Cr |
| 53 | Strides Pharma Science Limited | 13 funds | 0.32% | ₹400 Cr |
| 54 | Aarti Drugs Ltd | 13 funds | 0.37% | ₹458 Cr |
| 55 | Advanced Enzyme Technologies Limited | 13 funds | 0.24% | ₹58 Cr |
| 56 | Aarti Pharmalabs Limited | 13 funds | 0.31% | ₹46 Cr |
| 57 | Indoco Remedies Ltd | 12 funds | 0.46% | ₹336 Cr |
| 58 | FDC Limited | 12 funds | 0.59% | ₹384 Cr |
| 59 | Gufic Biosciences Ltd. | 11 funds | 0.54% | ₹131 Cr |
| 60 | Sun Pharma Advanced Research Company Limited | 10 funds | 0.09% | ₹6 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of August 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.